Zhu S - Search Results

1

MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression.

Wang A, Bu FT, Li JJ, Zhang YF, Jia PC, You HM, Wu S, Wu YY, Zhu S, Huang C, Li J. Wang A, et al. Among authors: zhu s. Toxicol Lett. 2022 Feb 1;355:88-99. doi: 10.1016/j.toxlet.2021.11.014. Epub 2021 Nov 25. Toxicol Lett. 2022. PMID: 34838997

2

Hesperetin derivative attenuates CCl₄-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms.

Chen X, Li XF, Chen Y, Zhu S, Li HD, Chen SY, Wang JN, Pan XY, Bu FT, Huang C, Li J. Chen X, et al. Among authors: zhu s. Int Immunopharmacol. 2019 Nov;76:105838. doi: 10.1016/j.intimp.2019.105838. Epub 2019 Aug 29. Int Immunopharmacol. 2019. PMID: 31473406

3

Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis.

Chen X, Li HD, Bu FT, Li XF, Chen Y, Zhu S, Wang JN, Chen SY, Sun YY, Pan XY, Yin NN, Xu JJ, Huang C, Li J. Chen X, et al. Among authors: zhu s. Theranostics. 2020 Mar 26;10(11):4851-4870. doi: 10.7150/thno.42423. eCollection 2020. Theranostics. 2020. PMID: 32308754 Free PMC article.

4

PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.

Chen Y, Chen X, Ji YR, Zhu S, Bu FT, Du XS, Meng XM, Huang C, Li J. Chen Y, et al. Among authors: zhu s. J Cell Mol Med. 2020 Jul;24(13):7405-7416. doi: 10.1111/jcmm.15356. Epub 2020 May 28. J Cell Mol Med. 2020. PMID: 32463161 Free PMC article.

5

Role of microRNAs in Hepatic Stellate Cells and Hepatic Fibrosis: An Update.

Zhu S, Chen X, Chen Y, Li XF, Chen SY, Li JJ, Wang A, Huang C, Li J. Zhu S, et al. Curr Pharm Des. 2021;27(27):3000-3011. doi: 10.2174/1381612826666201023143542. Curr Pharm Des. 2021. PMID: 33100194 Review.

6

Circular RNA circUbe2k promotes hepatic fibrosis via sponging miR-149-5p/TGF-β2 axis.

Zhu S, Chen X, Wang JN, Xu JJ, Wang A, Li JJ, Wu S, Wu YY, Li XF, Huang C, Li J. Zhu S, et al. FASEB J. 2021 Jun;35(6):e21622. doi: 10.1096/fj.202002738R. FASEB J. 2021. PMID: 33982351

7

Hesperetin derivative-16 attenuates CCl₄-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway.

Li JJ, Jiang HC, Wang A, Bu FT, Jia PC, Zhu S, Zhu L, Huang C, Li J. Li JJ, et al. Among authors: zhu s, zhu l. Eur J Pharmacol. 2022 Jan 15;915:174530. doi: 10.1016/j.ejphar.2021.174530. Epub 2021 Dec 10. Eur J Pharmacol. 2022. PMID: 34902361

8

Hesperetin derivative decreases CCl₄ -induced hepatic fibrosis by Ptch1-dependent mechanisms.

Zhu S, Chen X, Chen SY, Wang A, Wu S, Wu YY, Cheng M, Xu JJ, Li XF, Huang C, Li J. Zhu S, et al. J Biochem Mol Toxicol. 2022 Oct;36(10):e23149. doi: 10.1002/jbt.23149. Epub 2022 Jun 17. J Biochem Mol Toxicol. 2022. PMID: 35712856

9

miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β.

Chen X, Zhu S, Chen SY, Wang JN, Sun LJ, Tao SM, Li XF, Li HD, Sun YY, Xu CH, Suo XG, Ji ML, Huang C, Meng XM, Li J. Chen X, et al. Among authors: zhu s. Int Immunopharmacol. 2022 Sep;110:109034. doi: 10.1016/j.intimp.2022.109034. Epub 2022 Jul 11. Int Immunopharmacol. 2022. PMID: 35834952

10

Myc-mediated circular RNA circMcph1/miR-370-3p/Irak2 axis is a progressive regulator in hepatic fibrosis.

Xu JJ, Chen X, Zhu S, Jiang LF, Ma WX, Chen SY, Meng XM, Huang C, Li J. Xu JJ, et al. Among authors: zhu s. Life Sci. 2023 Jan 1;312:121182. doi: 10.1016/j.lfs.2022.121182. Epub 2022 Nov 24. Life Sci. 2023. PMID: 36435226 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,744 results

Search Page

Filters